Table of Contents 1 Ovarian Cancer Market Overview 1.1 Product Overview and Scope of Ovarian Cancer 1.2 Classification of Ovarian Cancer by Types 1.2.1 Global Ovarian Cancer Revenue Comparison by Types (2017-2023) 1.2.2 Global Ovarian Cancer Revenue Market Share by Types in 2017 1.2.3 Surgery 1.2.4 Chemotherapy 1.2.5 Radiation 1.2.6 Biological Therapy 1.3 Global Ovarian Cancer Market by Application 1.3.1 Global Ovarian Cancer Market Size and Market Share Comparison by Applications (2013-2023) 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Global Ovarian Cancer Market by Regions 1.4.1 Global Ovarian Cancer Market Size (Million USD) Comparison by Regions (2013-2023) 1.4.1 North America (USA, Canada and Mexico) Ovarian Cancer Status and Prospect (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Ovarian Cancer Status and Prospect (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ovarian Cancer Status and Prospect (2013-2023) 1.4.4 South America (Brazil, Argentina, Colombia) Ovarian Cancer Status and Prospect (2013-2023) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ovarian Cancer Status and Prospect (2013-2023) 1.5 Global Market Size of Ovarian Cancer (2013-2023) 2 Manufacturers Profiles 2.1 Bristol Myers Squibb 2.1.1 Business Overview 2.1.2 Ovarian Cancer Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Bristol Myers Squibb Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.2 Eli Lilly 2.2.1 Business Overview 2.2.2 Ovarian Cancer Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Eli Lilly Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.3 GlaxoSmithKline 2.3.1 Business Overview 2.3.2 Ovarian Cancer Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 GlaxoSmithKline Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.4 Janssen Pharmaceuticals 2.4.1 Business Overview 2.4.2 Ovarian Cancer Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Janssen Pharmaceuticals Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.5 Novogen 2.5.1 Business Overview 2.5.2 Ovarian Cancer Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Novogen Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.6 Genentech 2.6.1 Business Overview 2.6.2 Ovarian Cancer Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Genentech Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.7 Aetera Zenteris 2.7.1 Business Overview 2.7.2 Ovarian Cancer Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Aetera Zenteris Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.8 Boehringer Ingelheim 2.8.1 Business Overview 2.8.2 Ovarian Cancer Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Boehringer Ingelheim Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.9 Roche 2.9.1 Business Overview 2.9.2 Ovarian Cancer Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Roche Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) 3 Global Ovarian Cancer Market Competition, by Players 3.1 Global Ovarian Cancer Revenue and Share by Players (2013-2018) 3.2 Market Concentration Rate 3.2.1 Top 5 Ovarian Cancer Players Market Share 3.2.2 Top 10 Ovarian Cancer Players Market Share 3.3 Market Competition Trend 4 Global Ovarian Cancer Market Size by Regions 4.1 Global Ovarian Cancer Revenue and Market Share by Regions 4.2 North America Ovarian Cancer Revenue and Growth Rate (2013-2018) 4.3 Europe Ovarian Cancer Revenue and Growth Rate (2013-2018) 4.4 Asia-Pacific Ovarian Cancer Revenue and Growth Rate (2013-2018) 4.5 South America Ovarian Cancer Revenue and Growth Rate (2013-2018) 4.6 Middle East and Africa Ovarian Cancer Revenue and Growth Rate (2013-2018) 5 North America Ovarian Cancer Revenue by Countries 5.1 North America Ovarian Cancer Revenue by Countries (2013-2018) 5.2 USA Ovarian Cancer Revenue and Growth Rate (2013-2018) 5.3 Canada Ovarian Cancer Revenue and Growth Rate (2013-2018) 5.4 Mexico Ovarian Cancer Revenue and Growth Rate (2013-2018) 6 Europe Ovarian Cancer Revenue by Countries 6.1 Europe Ovarian Cancer Revenue by Countries (2013-2018) 6.2 Germany Ovarian Cancer Revenue and Growth Rate (2013-2018) 6.3 UK Ovarian Cancer Revenue and Growth Rate (2013-2018) 6.4 France Ovarian Cancer Revenue and Growth Rate (2013-2018) 6.5 Russia Ovarian Cancer Revenue and Growth Rate (2013-2018) 6.6 Italy Ovarian Cancer Revenue and Growth Rate (2013-2018) 7 Asia-Pacific Ovarian Cancer Revenue by Countries 7.1 Asia-Pacific Ovarian Cancer Revenue by Countries (2013-2018) 7.2 China Ovarian Cancer Revenue and Growth Rate (2013-2018) 7.3 Japan Ovarian Cancer Revenue and Growth Rate (2013-2018) 7.4 Korea Ovarian Cancer Revenue and Growth Rate (2013-2018) 7.5 India Ovarian Cancer Revenue and Growth Rate (2013-2018) 7.6 Southeast Asia Ovarian Cancer Revenue and Growth Rate (2013-2018) 8 South America Ovarian Cancer Revenue by Countries 8.1 South America Ovarian Cancer Revenue by Countries (2013-2018) 8.2 Brazil Ovarian Cancer Revenue and Growth Rate (2013-2018) 8.3 Argentina Ovarian Cancer Revenue and Growth Rate (2013-2018) 8.4 Colombia Ovarian Cancer Revenue and Growth Rate (2013-2018) 9 Middle East and Africa Revenue Ovarian Cancer by Countries 9.1 Middle East and Africa Ovarian Cancer Revenue by Countries (2013-2018) 9.2 Saudi Arabia Ovarian Cancer Revenue and Growth Rate (2013-2018) 9.3 UAE Ovarian Cancer Revenue and Growth Rate (2013-2018) 9.4 Egypt Ovarian Cancer Revenue and Growth Rate (2013-2018) 9.5 Nigeria Ovarian Cancer Revenue and Growth Rate (2013-2018) 9.6 South Africa Ovarian Cancer Revenue and Growth Rate (2013-2018) 10 Global Ovarian Cancer Market Segment by Type 10.1 Global Ovarian Cancer Revenue and Market Share by Type (2013-2018) 10.2 Global Ovarian Cancer Market Forecast by Type (2018-2023) 10.3 Surgery Revenue Growth Rate (2013-2023) 10.4 Chemotherapy Revenue Growth Rate (2013-2023) 10.5 Radiation Revenue Growth Rate (2013-2023) 10.6 Biological Therapy Revenue Growth Rate (2013-2023) 11 Global Ovarian Cancer Market Segment by Application 11.1 Global Ovarian Cancer Revenue Market Share by Application (2013-2018) 11.2 Ovarian Cancer Market Forecast by Application (2018-2023) 11.3 Hospitals Revenue Growth (2013-2018) 11.4 Clinics Revenue Growth (2013-2018) 11.5 Others Revenue Growth (2013-2018) 12 Global Ovarian Cancer Market Size Forecast (2018-2023) 12.1 Global Ovarian Cancer Market Size Forecast (2018-2023) 12.2 Global Ovarian Cancer Market Forecast by Regions (2018-2023) 12.3 North America Ovarian Cancer Revenue Market Forecast (2018-2023) 12.4 Europe Ovarian Cancer Revenue Market Forecast (2018-2023) 12.5 Asia-Pacific Ovarian Cancer Revenue Market Forecast (2018-2023) 12.6 South America Ovarian Cancer Revenue Market Forecast (2018-2023) 12.7 Middle East and Africa Ovarian Cancer Revenue Market Forecast (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Ovarian Cancer Picture Table Product Specifications of Ovarian Cancer Table Global Ovarian Cancer and Revenue (Million USD) Market Split by Product Type Figure Global Ovarian Cancer Revenue Market Share by Types in 2017 Figure Surgery Picture Figure Chemotherapy Picture Figure Radiation Picture Figure Biological Therapy Picture Table Global Ovarian Cancer Revenue (Million USD) by Application (2013-2023) Figure Ovarian Cancer Revenue Market Share by Applications in 2017 Figure Hospitals Picture Figure Clinics Picture Figure Others Picture Table Global Market Ovarian Cancer Revenue (Million USD) Comparison by Regions 2013-2023 Figure North America Ovarian Cancer Revenue (Million USD) and Growth Rate (2013-2023) Figure Europe Ovarian Cancer Revenue (Million USD) and Growth Rate (2013-2023) Figure Asia-Pacific Ovarian Cancer Revenue (Million USD) and Growth Rate (2013-2023) Figure South America Ovarian Cancer Revenue (Million USD) and Growth Rate (2013-2023) Figure Middle East and Africa Ovarian Cancer Revenue (Million USD) and Growth Rate (2013-2023) Figure Global Ovarian Cancer Revenue (Million USD) and Growth Rate (2013-2023) Table Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors Table Bristol Myers Squibb Ovarian Cancer Type and Applications Table Bristol Myers Squibb Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Eli Lilly Basic Information, Manufacturing Base and Competitors Table Eli Lilly Ovarian Cancer Type and Applications Table Eli Lilly Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline Ovarian Cancer Type and Applications Table GlaxoSmithKline Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Janssen Pharmaceuticals Ovarian Cancer Type and Applications Table Janssen Pharmaceuticals Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Novogen Basic Information, Manufacturing Base and Competitors Table Novogen Ovarian Cancer Type and Applications Table Novogen Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Genentech Basic Information, Manufacturing Base and Competitors Table Genentech Ovarian Cancer Type and Applications Table Genentech Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Aetera Zenteris Basic Information, Manufacturing Base and Competitors Table Aetera Zenteris Ovarian Cancer Type and Applications Table Aetera Zenteris Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors Table Boehringer Ingelheim Ovarian Cancer Type and Applications Table Boehringer Ingelheim Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Roche Basic Information, Manufacturing Base and Competitors Table Roche Ovarian Cancer Type and Applications Table Roche Ovarian Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Global Ovarian Cancer Revenue (Million USD) by Players (2013-2018) Table Global Ovarian Cancer Revenue Share by Players (2013-2018) Figure Global Ovarian Cancer Revenue Share by Players in 2016 Figure Global Ovarian Cancer Revenue Share by Players in 2017 Figure Global Top 5 Players Ovarian Cancer Revenue Market Share in 2017 Figure Global Top 10 Players Ovarian Cancer Revenue Market Share in 2017 Figure Global Ovarian Cancer Revenue (Million USD) and Growth Rate (%) (2013-2018) Table Global Ovarian Cancer Revenue (Million USD) by Regions (2013-2018) Table Global Ovarian Cancer Revenue Market Share by Regions (2013-2018) Figure Global Ovarian Cancer Revenue Market Share by Regions (2013-2018) Figure Global Ovarian Cancer Revenue Market Share by Regions in 2017 Figure North America Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure Europe Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure Asia-Pacific Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure South America Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure Middle East and Africa Ovarian Cancer Revenue and Growth Rate (2013-2018) Table North America Ovarian Cancer Revenue by Countries (2013-2018) Table North America Ovarian Cancer Revenue Market Share by Countries (2013-2018) Figure North America Ovarian Cancer Revenue Market Share by Countries (2013-2018) Figure North America Ovarian Cancer Revenue Market Share by Countries in 2017 Figure USA Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure Canada Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure Mexico Ovarian Cancer Revenue and Growth Rate (2013-2018) Table Europe Ovarian Cancer Revenue (Million USD) by Countries (2013-2018) Figure Europe Ovarian Cancer Revenue Market Share by Countries (2013-2018) Figure Europe Ovarian Cancer Revenue Market Share by Countries in 2017 Figure Germany Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure UK Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure France Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure Russia Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure Italy Ovarian Cancer Revenue and Growth Rate (2013-2018) Table Asia-Pacific Ovarian Cancer Revenue (Million USD) by Countries (2013-2018) Figure Asia-Pacific Ovarian Cancer Revenue Market Share by Countries (2013-2018) Figure Asia-Pacific Ovarian Cancer Revenue Market Share by Countries in 2017 Figure China Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure Japan Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure Korea Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure India Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure Southeast Asia Ovarian Cancer Revenue and Growth Rate (2013-2018) Table South America Ovarian Cancer Revenue by Countries (2013-2018) Table South America Ovarian Cancer Revenue Market Share by Countries (2013-2018) Figure South America Ovarian Cancer Revenue Market Share by Countries (2013-2018) Figure South America Ovarian Cancer Revenue Market Share by Countries in 2017 Figure Brazil Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure Argentina Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure Colombia Ovarian Cancer Revenue and Growth Rate (2013-2018) Table Middle East and Africa Ovarian Cancer Revenue (Million USD) by Countries (2013-2018) Table Middle East and Africa Ovarian Cancer Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Ovarian Cancer Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Ovarian Cancer Revenue Market Share by Countries in 2017 Figure Saudi Arabia Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure UAE Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure Egypt Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure Nigeria Ovarian Cancer Revenue and Growth Rate (2013-2018) Figure South Africa Ovarian Cancer Revenue and Growth Rate (2013-2018) Table Global Ovarian Cancer Revenue (Million USD) by Type (2013-2018) Table Global Ovarian Cancer Revenue Share by Type (2013-2018) Figure Global Ovarian Cancer Revenue Share by Type (2013-2018) Figure Global Ovarian Cancer Revenue Share by Type in 2017 Table Global Ovarian Cancer Revenue Forecast by Type (2018-2023) Figure Global Ovarian Cancer Market Share Forecast by Type (2018-2023) Figure Global Surgery Revenue Growth Rate (2013-2018) Figure Global Chemotherapy Revenue Growth Rate (2013-2018) Figure Global Radiation Revenue Growth Rate (2013-2018) Figure Global Biological Therapy Revenue Growth Rate (2013-2018) Table Global Ovarian Cancer Revenue by Application (2013-2018) Table Global Ovarian Cancer Revenue Share by Application (2013-2018) Figure Global Ovarian Cancer Revenue Share by Application (2013-2018) Figure Global Ovarian Cancer Revenue Share by Application in 2017 Table Global Ovarian Cancer Revenue Forecast by Application (2018-2023) Figure Global Ovarian Cancer Market Share Forecast by Application (2018-2023) Figure Global Hospitals Revenue Growth Rate (2013-2018) Figure Global Clinics Revenue Growth Rate (2013-2018) Figure Global Others Revenue Growth Rate (2013-2018) Figure Global Ovarian Cancer Revenue (Million USD) and Growth Rate Forecast (2018 -2023) Table Global Ovarian Cancer Revenue (Million USD) Forecast by Regions (2018-2023) Figure Global Ovarian Cancer Revenue Market Share Forecast by Regions (2018-2023) Figure North America Ovarian Cancer Revenue Market Forecast (2018-2023) Figure Europe Ovarian Cancer Revenue Market Forecast (2018-2023) Figure Asia-Pacific Ovarian Cancer Revenue Market Forecast (2018-2023) Figure South America Ovarian Cancer Revenue Market Forecast (2018-2023) Figure Middle East and Africa Ovarian Cancer Revenue Market Forecast (2018-2023)

Bristol Myers Squibb Eli Lilly GlaxoSmithKline Janssen Pharmaceuticals Novogen Genentech Aetera Zenteris Boehringer Ingelheim Roche